Boston Scientific
BSX
Boston Scientific (BSX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.86
- EPS estimate
- $0.83
- EPS surprise
- +3.90%
- Revenue surprise
- +1.44%
- Revenue
- $5.4B
- Revenue estimate
- $5.4B
- Reported
- Jul 29, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | $0.83 | $0.86 | +3.90% | $5.4B | SEC |
| Q1 2026 | Apr 22, 2026 | $0.79 | $0.80 | +1.51% | $5.2B | SEC |
| Q4 2025 | Feb 4, 2026 | $0.78 | $0.80 | +2.56% | $5.3B | SEC |
| Q3 2025 | Oct 22, 2025 | $0.71 | $0.75 | +5.09% | $5.1B | SEC |
| Q2 2025 | Jul 23, 2025 | $0.73 | $0.75 | +3.38% | $5.1B | SEC |
| Q1 2025 | Apr 23, 2025 | $0.67 | $0.75 | +11.46% | $4.7B | SEC |
| Q4 2024 | Feb 5, 2025 | $0.66 | $0.70 | +6.53% | $4.6B | SEC |
| Q3 2024 | Oct 23, 2024 | $0.59 | $0.63 | +7.09% | $4.2B | SEC |
| Q2 2024 | Jul 24, 2024 | $0.58 | $0.62 | +6.27% | $4.1B | SEC |
| Q1 2024 | Apr 24, 2024 | $0.51 | $0.56 | +9.03% | $3.9B | SEC |
| Q4 2023 | Jan 31, 2024 | $0.51 | $0.55 | +7.23% | $3.7B | SEC |
| Q3 2023 | Oct 26, 2023 | $0.48 | $0.50 | +4.76% | $3.5B | SEC |
| Q2 2023 | Jul 27, 2023 | $0.49 | $0.53 | +8.16% | $3.6B | SEC |
| Q1 2023 | Apr 26, 2023 | $0.43 | $0.47 | +8.60% | $3.4B | SEC |
| Q4 2022 | Feb 1, 2023 | $0.47 | $0.45 | −4.60% | $3.2B | SEC |
| Q3 2022 | Oct 26, 2022 | $0.44 | $0.43 | −2.56% | $3.2B | SEC |
| Q2 2022 | Jul 27, 2022 | $0.42 | $0.44 | +3.95% | $3.2B | SEC |
| Q1 2022 | Apr 27, 2022 | $0.38 | $0.39 | +1.35% | $3.0B | SEC |
| Q4 2021 | Feb 2, 2022 | $0.44 | $0.45 | +2.51% | $3.1B | SEC |
| Q3 2021 | Oct 27, 2021 | $0.40 | $0.41 | +3.69% | $2.9B | SEC |
Quarterly revenue
Frequently asked questions
When did Boston Scientific (BSX) last report earnings?
Boston Scientific last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did BSX beat earnings estimates?
Yes. Boston Scientific reported EPS of $0.86 for Q2 2026 against a $0.83 estimate — a 3.90% beat.
How much revenue did BSX report last quarter?
Boston Scientific reported $5.4B in revenue for Q2 2026, against a consensus estimate of $5.4B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.